Orbimed Advisors Llc Gemini Therapeutics, Inc. (GMTX) insider trading activity
Orbimed Advisors LLC is Director of Gemini Therapeutics, Inc. . Currently has a direct ownership of 0 shares of GMTX, which is worth approximately $0. The most recent transaction as insider was on Dec 18, 2023, when has been sold 1,724 shares (Common Stock) at a price of $59.24 per share, resulting in proceeds of $102,129. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
n/a
12M change
Total Value Held
$0
ORBIMED ADVISORS LLC Transaction History
Also insider at
OAL
Orbimed Advisors LLC
Director
San Diego, CA